David Mitchell, a cancer patient and the founder of Patients For Affordable Drugs, will testify today before a U.S. House of Representatives subcommittee at the hearing, “Profits Over Consumers: Exposing How Pharmaceutical Corporations Game the System.”
"The pharmaceutical industry is now the most poorly regarded industry in Americans' eyes, ranking last on a list of 25 industries that Gallup tests annually."
Government policy keeps U.S. drug prices high, and only government reforms can change that.
Patients For Affordable Drugs Sends Petition, Letter to Francis Collins Asking for Pricing Guardrails on Taxpayer-funded Drugs.
House Oversight hearing examines the impact of high prescription drug prices on American families.
Read an advance copy of his remarks.
Drug Corporation Alleged To Have Taken Actions To Block Generic Competition and Raised Prices at Expense of Cancer Patients and Taxpayers.
This could be a cure for a disease that is devastating and disproportionately impacts marginalized communities.
Patients For Affordable Drugs is the only independent national patient organization focused exclusively on achieving policy changes to lower the price of prescription drugs.
